Latest Post

December 28, 2020

Particles in Injectable Drugs

A parenteral drug product contaminated by particles is a potential health threat. In the bloodstream, particles can cause serious issues, such as capillary occlusion and immunogenic responses. In most cases, the observation of particles in a drug product leads to a recall.
Lynn Yao

Lynn Yao

Manager, Scientific Affairs, CN

Categories

Search the Blog

Archive

{1}

{2}
{3}

{4}

  • Previous Posts
    SmartDose Platform

    April 26, 2019

    Overcoming Challenges Associated with Biologic Drug Formulation and Development

    Victoria Morgan

    Victoria Morgan

    Director, Segment Marketing, Global Biologics

    SmartDose, Elastomers, Seals and Syringe plungers

    September 11, 2018

    Supporting Patient Safety – Contribution By Drug Containment Solutions

    Heike Kofler

    Heike Kofler, Ph.D.

    Manager, Technical Customer Support

    Envision Verification Process

    July 16, 2018

    Three Questions to Ask to Improve Your Injectable Drug Packaging Process

    Bill Matakas

    Bill Matakas

    Senior Director, Product Management & Marketing Operations

    Daikyo Crystal Zentih Leur Lock Syringe

    May 01, 2018

    Addressing the Complexities of Ophthalmic Drug Delivery

    Susan Dounce

    Susan Dounce

    Principal SME, Prefilled Syringes, Crystal Zenith, Combination Products

    Load more